Key facts
- Logos Capital is a hedge fund based in San Francisco, California with 29 tracked portfolio companies.
- Notable positions include Freenome, Element Biosciences, Mirador Therapeutics, 35Pharma, Odyssey Therapeutics.
- The team roster lists 4 people.
About Logos Capital
Founded in 2019, Logos Capital is a hedge fund manager based in San Francisco, California. The firm prefers fundamental biotechnology-focused investments. The firm employs fundamental & sector-oriented equity strategies.
Free account
See the whole book
- ·The book's top 25 — of 29 recorded positions
- ·Watchlist + alerts for Logos Capital's activity
Create free account
No card required
Portfolio, priced
29 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | $2.2B | — | |
| Element Biosciences | Other Healthcare Technology Systems | $1.0B | — | |
| Mirador Therapeutics | — | $1.0B | — | |
| 35Pharma | — | $950.0M | — | |
| Odyssey Therapeutics | Biotechnology | $638.2M | — | |
| Diagonal Therapeutics | Drug Discovery | $458.5M | — | |
| Attovia Therapeutics | — | $370.0M | — | |
| Interius BioTherapeutics | — | $350.0M | — | |
| Aviceda Therapeutics | — | $346.5M | — | |
| Beacon Biosignals | — | $334.0M | — | |
| Third Arc Bio | — | $314.0M | — | |
| Vanqua Bio | — | $270.0M | — | |
| TRIANA Biomedicines | Discovery Tools (Healthcare) | $258.0M | — | |
| Arbor Biotechnologies | — | $238.9M | — | |
| Parse Biosciences | — | $225.0M | — | |
| + 14 more companies · a free account shows the top of the book | ||||
Team
4 people on record — 4 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does Logos Capital invest in?
- Logos Capital has 29 recorded portfolio companies, including Freenome, Element Biosciences, Mirador Therapeutics, 35Pharma.
- What is Logos Capital's AUM?
- Logos Capital manages approximately $1.4B in assets.